RVMD

Q: What is the price of Revolution Medicines (RVMD) today?

A cotação de Revolution Medicines (RVMD) hoje está em $ 149.94, com uma variação de The stock began the year trading around $ 79.65 and is currently priced at $ 149.94. negociando na casa dos $ 79.65 e hoje está em $ 149.94. Acompanhe o and track broader market trends directly on the platform.

Q: When does Revolution Medicines (RVMD) pay dividends?

Revolution Medicines (RVMD) did not pay dividends over the past year.

Q: Is Revolution Medicines (RVMD) a good investment?

Atualmente, Revolution Medicines (RVMD) está cotada a $ 149.94, com um P/L de -20.47, This represents a -1,274% premium compared to its historical average P/E. uma variação de 275.32 em sua cotação e distribuiu $ 0.00 em dividendos, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 275.32%.Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

Revolution Medicines Inc.

Price

$ 149.94

return (12m)

275.32%

p/e

-20.47

p/bv

18.72

DIVIDEND YIELD

0.00%

RVMD price

RVMD

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment RVMD

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

10.01%

3 months

54.05%

1 year

275.32%

2 years

303.39%

5 years

368.71%

10 years

0.00%

Fundamentals RVMD

review the fundamentals of Revolution Medicines shares

P/E

-20.47

Sector: -4.15 Industry: -4.15

P/S (PSR)

Sector: -3.93 Industry: -3.93

P/BV

18.72

Sector: 1.97 Industry: 1.97

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

-60.86%

Sector: -61.93% Industry: -61.93%

ROE

-91.45%

Sector: -61.48% Industry: -61.48%

ROIC

-515.50%

Sector: -2,151.51% Industry: -2,151.51%

NET MARGIN

0.00%

Sector: -39.79% Industry: -39.79%

GROSS MARGIN

0.00%

Sector: 37.04% Industry: 37.04%

OPERATING MARGIN

0.00%

Sector: -39.10% Industry: -39.10%

EV/EBITDA

-21.02

Sector: -4.21 Industry: -4.21

EV/EBIT

-20.75

Sector: -4.25 Industry: -4.25

PRICE-TO-ASSETS

12.46

Sector: 1.41 Industry: 1.41

BVPS

7.58

Sector: 1.87 Industry: 1.87

EPS

-6.93

Sector: -2.08 Industry: -2.08

EQUITY-TO-ASSETS RATIO

0.67

Sector: 0.42 Industry: 0.42

LIABILITIES / ASSETS

0.33

Sector: 0.39 Industry: 0.39

CAGR REVENUE 5 YEARS

0.00%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

48.95%

Sector: - Industry: -

Fundamentals RVMD

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
JNJ	25.34	6.57	25.92%	2.35%	$ 533.16 B	21.83%
PFE	19.20	1.59	8.29%	6.81%	$ 143.77 B	11.83%
ABBV	98.09	0.00	0.00%	3.30%	$ 356.54 B	5.79%
NVO	10.79	6.52	60.40%	4.05%	$ 204.69 B	37.15%
MRK	30.79	0.00	0.00%	2.98%	$ 275.11 B	13.59%
AZN	27.26	5.98	21.93%	1.75%	$ 283.23 B	17.19%
GILD	17.70	6.96	39.33%	2.43%	$ 163.11 B	30.99%
BMY	15.73	0.00	0.00%	4.45%	$ 114.45 B	15.01%
ZTS	13.23	10.81	81.75%	2.45%	$ 34.95 B	27.79%
REGN	16.81	2.37	14.08%	0.50%	$ 74.35 B	29.65%
HALO	23.88	155.01	649.21%	0.00%	$ 7.57 B	22.69%
AMGN	22.96	19.49	84.87%	2.91%	$ 179.12 B	20.96%
MCK	18.86	-107.68	-570.98%	0.43%	$ 89.80 B	1.18%
HRMY	12.34	1.97	16.00%	0.00%	$ 1.80 B	16.20%
VRTX	25.17	5.64	22.41%	0.00%	$ 109.17 B	35.51%
CAH	27.75	-16.15	-58.20%	1.11%	$ 43.16 B	0.62%
ADMA	11.66	4.94	42.37%	0.00%	$ 1.93 B	32.43%
BIIB	20.73	1.52	7.36%	0.00%	$ 28.44 B	13.81%

Stock vs Indice Comparison Tool

If you had invested

years ago

2 years

5 years

10 years

ago, you would now have *

ago, you would now have:

*The value considers the reinvestment of dividends.

RVMD Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Revolution Medicines

Revolution Medicines Inc.

Average Investor10 user rating

4.0 (0 people)

United States

12 years

Founded: 2014

2020

Time since IPO - 6 years

125

Employees

Revolution Medicines Inc. (United States) is listed on the Nasdaq and has a market capitalization of $28.08 Billions, with shareholders equity totaling $1.50 Billion.

The company employs approximately 125 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Revolution Medicines Inc. reported $- in revenue, generating net income of $-1.37 Billion.

Key financial metrics include a P/E ratio of -20.47, a price-to-book (P/B) ratio of 18.72, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker RVMD.

Market cap

$ 28.08 Billions

Net worth

$ 1.50 Billion

$ 1,499,920,000.00

Assets

$ 2.25 Billions

$ 2,253,740,000.00

Total Shares Outstanding

198.00 Millions

198,000,000

Average Daily Trading Volume

$ 3.19 Millions

$ 3,185,176.60

Sector

Health Care

Industry

Biotechnology

RVMD

RVMD revenue and profits

Financial Results RVMD

DRAG THE FRAME TO SEE MORE DATA

RVMD cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

BFRA - Biofrontera

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$ 737.18 8,59% (12M)

P/E

18.86

0.43%

ROE

-570.98%

P/BV

-107.68

CAH - Cardinal Health

$ 186.35 27,34% (12M)

P/E

27.75

1.11%

ROE

-58.20%

P/BV

-16.15

JNJ - Johnson & Johnson

$ 230.42 62,81% (12M)

P/E

25.34

2.35%

ROE

25.92%

P/BV

6.57

MRK - Merck & Co.

$ 113.45 60,03% (12M)

P/E

30.79

2.98%

ROE

0.00%

P/BV

0.00

AZN - AstraZeneca

$ 187.72 40,58% (12M)

P/E

27.26

1.75%

ROE

21.93%

P/BV

5.98

ABBV - AbbVie

$ 208.50 21,24% (12M)

P/E

98.09

3.30%

ROE

0.00%

P/BV

0.00

NVO - Novo Nordisk

$ 47.08 --23,37% (12M)

P/E

10.79

4.05%

ROE

60.40%

P/BV

6.52

BFRA - Biofrontera

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$ 737.18 8,59% (12 M)

P/L

18.86

0.43%

ROE

-570.98%

P/VP

-107.68

CAH - Cardinal Health

$ 186.35 27,34% (12 M)

P/L

27.75

1.11%

ROE

-58.20%

P/VP

-16.15

JNJ - Johnson & Johnson

$ 230.42 62,81% (12 M)

P/L

25.34

2.35%

ROE

25.92%

P/VP

6.57

MRK - Merck & Co.

$ 113.45 60,03% (12 M)

P/L

30.79

2.98%

ROE

0.00%

P/VP

0.00

AZN - AstraZeneca

$ 187.72 40,58% (12 M)

P/L

27.26

1.75%

ROE

21.93%

P/VP

5.98

ABBV - AbbVie

$ 208.50 21,24% (12 M)

P/L

98.09

3.30%

ROE

0.00%

P/VP

0.00

NVO - Novo Nordisk

$ 47.08 --23,37% (12 M)

P/L

10.79

4.05%

ROE

60.40%

P/VP

6.52

Frequently Asked Questions

What is the price of Revolution Medicines (RVMD) today?

A cotação de Revolution Medicines (RVMD) hoje está em $ 149.94, com uma variação de The stock began the year trading around $ 79.65 and is currently priced at $ 149.94. negociando na casa dos $ 79.65 e hoje está em $ 149.94. Acompanhe o and track broader market trends directly on the platform.

When does Revolution Medicines (RVMD) pay dividends?

Revolution Medicines (RVMD) did not pay dividends over the past year.

Is Revolution Medicines (RVMD) a good investment?

Atualmente, Revolution Medicines (RVMD) está cotada a $ 149.94, com um P/L de -20.47, This represents a -1,274% premium compared to its historical average P/E. uma variação de 275.32 em sua cotação e distribuiu $ 0.00 em dividendos, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 275.32%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Revolution Medicines (RVMD) stock?

You can buy Revolution Medicines (RVMD) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol RVMD and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of Revolution Medicines (RVMD) yield today?

Over the past month, Revolution Medicines (RVMD) has returned 10.01% — 275.32% over the past year, and 368.71% over the past five years, including price appreciation and dividends.

Nos últimos 12 meses, a empresa pagou um total de $ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Revolution Medicines (RVMD) hoje, o investimento total seria de $ 14,994.00, com base na cotação atual de $ 149.94.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: $ 56,275.48
Em 5 anos: $ 70,278.38
Em 10 anos: $ 14,994.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

RVMD

Revolution Medicines Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment RVMD

review the fundamentals of Revolution Medicines shares

P/E

P/S (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

EV/EBITDA

EV/EBIT

PRICE-TO-ASSETS

BVPS

EPS

EQUITY-TO-ASSETS RATIO

LIABILITIES / ASSETS

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Revolution Medicines

Revolution Medicines Inc.

United States

12 years

2020

125

PROFIT X PRICE RVMD

Financial Results RVMD

RVMD cash flow

Asset, Revenue and Profit Growth - RVMD

RVMD balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

AZN - AstraZeneca

ABBV - AbbVie

NVO - Novo Nordisk

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

AZN - AstraZeneca

ABBV - AbbVie

NVO - Novo Nordisk

Frequently Asked Questions